Point72 Asia (Singapore)’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-336
Closed -$146K 991
2025
Q1
$146K Buy
+336
New +$135K 0.04% 332
2024
Q3
Sell
-5,270
Closed -$2.86M 1075
2024
Q2
$2.86M Buy
+5,270
New +$2.79M 0.59% 37
2024
Q1
Sell
-586
Closed -$276K 1112
2023
Q4
$276K Buy
+586
New +$271K 0.07% 115

Other funds holding ELV

Point72 Asia (Singapore)'s ELV Position: Q2 2025 in Review

Point72 Asia (Singapore) sold out of Elevance Health (ELV) in Q2 2025, closing a stake of 336 shares — an estimated $146K sold.

Point72 Asia (Singapore) first reported a position in ELV in Q4 2023 and held it in 3 quarters. The position peaked at $2.86M in Q2 2024. 1,589 funds tracked by Wall St. Rank hold ELV as of Q2 2025.

  • Point72 Asia (Singapore) reported no remaining Elevance Health position as of Q2 2025 after selling out during the quarter.
  • Point72 Asia (Singapore) sold 336 Elevance Health shares in Q2 2025, an estimated $146K.
  • Point72 Asia (Singapore) first reported a position in Elevance Health in Q4 2023 and held it in 3 quarters.
  • Point72 Asia (Singapore)'s Elevance Health position peaked at $2.86M in Q2 2024.
  • 1,589 funds tracked by Wall St. Rank held Elevance Health as of Q2 2025.

Based on Point72 Asia (Singapore)'s 13F filing for Q2 2025, filed 14 Aug 2025.